Value of endoscopic retrograde cholangiopancreatography-guided brushings in preoperative assessment of pancreaticobiliary strictures: What's new?

Acta Cytologica

Volumn 52, Issue 1, 2008, Pages 24-34

  Athanassiadou, Pauline ^a   Grapsa, Dimitra ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Bile duct; Brushing; Cytology; Endoscopic retrograde cholangiopancreatography bile duct; Pancreas

Indexed keywords

BILE DUCT OBSTRUCTION; CYTODIAGNOSIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HUMAN; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; PANCREAS DUCT STENOSIS; PRIORITY JOURNAL; REVIEW;

EID: 38549096063     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000325431     Document Type: Review

References (119)

1. Geisinger KR, Stanley MW, Raab SS, Silverman JF, Abati A: Modern Cytopathology. Philadelphia, Churchill Livingstone, 2004, pp 491-503
2. Carriage MT, Henson DE: Liver, gallbladder, extrahepatic bile ducts and pancreas. Cancer 1995;75:171-190
3. Solcia E, Capella C, Kloppel G: Tumors of the pancreas. In Atlas of Tumor Pathology. Third Series, Fascicle 27. Washington, DC, Armed Forces Institute of Pathology, 2000, pp 53-64
4. Rosai J: Gallbladder and extrahepatic bile ducts. In Rosai and Ackerman's Surgical Pathology. Ninth edition. Edited by J Rosai. Edinburgh, Mosby, 2004, pp 1049-1050
5. Koss LG, Melamed MR: The duodenum, extrahepatic bile ducts, pancreatic ducts, and gallbladder. In Koss' Diagnostic Cytology and Its Histopathologic Bases. Fifth edition. Edited by LG Koss. Lippincott Williams & Willems, 2006, pp 896-909
6. Gudjonsson B: Pancreatic cancer: Is surgery curing more people? No. In Controversies and Clinical Challenges in Pancreatic Diseases. New Orleans, American Gastroenterological Association Postgraduate Course, 1998, pp 251-258
7. Hruban RH, Argani P, Ali SZ: The pancreas and extrahepatic biliary system. In Silveberg's Principles and Practice of Surgical Pathology and Cytopathology. Edited by SG Silveberg, RA DeLellis, WJ Frable, VA LiVolsi, MR Wick. Philadelphia, Churchill Livingstone, 2006, pp 1549-1596
8. Thompson LDR, Heffess CS: Pancreas. In Sternberg's Diagnostic Surgical Pathology. Fourth edition. Edited by SE Mills, D Carter, JK Greenson, HA Oberman, VE Reuter, MH Stoler. Philadelphia, Lippincott Williams & Wilkins, 2004, pp 1603-1654
9. Sterrett GF, Frost FA, Whitaker D: Gallbladder and extra-hepatic bile ducts. In Diagnostic Cytopathology. Edited by W Gray, GT McKee. Philadelphia, Churchill Livingstone, 2003, pp 413-424
10. de Bellis M, Fogel EL, Sherman S, Watkins JL, Chappo J, Younger C, Cramer H, Lehman GA: Influence of stricture dilation and repeat brushing on the cancer detection rate of brush cytology in the evaluation of malignant biliary obstruction. Gastrointest Endosc 2003;58:176-182
11. De May RM: The Art and Science of Cytopathology: Pancreas. Chicago, ASCP Press, 1996, pp 413-424
12. Enayati PG, Traverso W, Galagan K, Thirlby RC, Larson J, Hauptman EM, Kozarek PA: The meaning of equivocal pancreatic cytology in patients thought to have pancreatic cancer. Am J Surg 1996;171:525-528
13. Delbeke D, Pinson W: Pancreatic tumors: Role of imaging in the diagnosis, staging and treatment. J Hepatobiliary Pancreat Surg 2004;11:4-10
14. Siddiqui MT, Gokaslan ST, Saboorian MH, Carrick K, Ashfaq R: Comparison of ThinPrep and conventional smears in detecting carcinoma in bile duct brushings. Cancer Cytopathol 2003;99:205-210
15. Chen VK, Arguedas MR, Kilgore ML, Eloubeidi MA: A cost-minimization analysis of alternative strategies in diagnosing pancreatic cancer. Am J Gastroenterol 2004;99:2223-2234
16. Mansfield JC, Griffin SM, Wadehra V, Matthewson K: A prospective evaluation of cytology from biliary strictures. Gut 1997;40:671-677
17. Whipple AO, Parsons WB, Mullins CR: Treatment of carcinoma of the ampulla of Vater. Ann Surg 1935;102:763-779
18. Grace PA, Pitt HA, Tompkins RK, Denbensten L, Longmire WP: Decreased morbidity and mortality after pancreatoduodenectomy. Am J Surg 1986;151:141-149
19. Yeo CJ, Cameron JL: Improving results of pancreaticoduodenectomy for pancreatic cancer. World J Surg 1999;23:907-912
20. Kurzawinski T, Deery A, Davidson BR: Diagnostic value of cytology for biliary stricture. Br J Surg 1993;80:414-421
21. ASGE Guideline: The role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc 2005;62:1-8
22. Lee JG: Brush cytology and the diagnosis of pancreaticobiliary malignancy during ERCP (edit). Gastrointest Endosc 2006;63:78-80
23. Ponchon T, Gagnon P, Berger F, Labadie M, Liaras A, Chavaillon A, Bory R: Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: Results of a prospective study. Gastrointest Endosc 1995;42:565-572
24. Foutch PG: Diagnosis of cancer by cytologic methods performed during ERCP. Gastrointest Endosc 1994;40:249-252
25. Howell LP, Chow H-C, Russell LA: Cytodiagnosis of extra-hepatic biliary duct tumours from specimens obtained during cholangiography. Diagn Cytopathol 1988;4:328-334
26. Teplick SK, Haskin PH, Kline S, Sammon JK, Laffey PA: Percutaneous pancreatobiliary biopsies in 173 patients using primarily ultrasound or fluoroscopic guidance. Cardiovasc Intervent Radiol 1988;11:26-28
27. Warshaw AL: Implications of peritoneal cytology for staging early pancreatic cancer. Am J Surg 1991;161:26-29
28. Ferrucci JT, Wittenberg J, Margolies MN, Carey RW: Malignant seeding of the tract after thin-needle aspiration biopsy. Radiology 1979;130:345-346
29. Ferrari AP Jr, Lichtenstein DR, Slivka A: Brush cytology during ERCP for the diagnosis of biliary and pancreatic malignancies. Gastrointest Endosc 1994;40:140-145
30. Sawada Y, Gonda H, Hayashida Y: Combined use of brushing cytology and endoscopic retrograde pancreatography for the early detection of pancreatic cancer. Acta Cytol 1989;33:870-874
31. Rabinovitz M, Zajko AB, Hassanein T, Shetty B, Bron KM, Schade RR, Gavaler JS, Block G, van Thiel DH, Dekker A: Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: A study in 65 patients with bile duct strictures. Hepatology 1990;12:747-752
32. Foutch PG, Kerr DM, Harlan JR, Kummet TD: A prospective, controlled analysis of endoscopic cytotechniques for diagnosis of malignant biliary strictures. Am J Gastroenterol 1991;86:577-580
33. Scudera PL, Koizumi J, Jacobson IM: Brush cytology evaluation of lesions encountered during ERCP. Gastrointest Endosc 1990;36:281-284
34. Witte S, Langer J: Endoscopic cytodiagnosis of the pancreas and bile ducts. Med Klin (Munich) 1991;86:449-453
35. Lee JG, Leung JW, Baillie J, Layfield LJ, Cotton PB: Benign, dysplastic, or malignant-making sense of endoscopic brush cytology: Results in 149 consecutive patients. Am J Gastroenterol 1995;90:722-726
36. Pugliese V, Conio M, Nicolo G, Saccomanno S, Gatteschi B: Endoscopic retrograde forceps biopsy and brush cytology of biliary strictures: A prospective study. Gastrointest Endoscop 1995;42:520-526
37. Kocjan G, Smith AN: Bile duct brushings cytology: Potential pitfalls in diagnosis. Diagn Cytopathol 1997;16:358-363
38. Stewart CJ, Mills PR, Carter R, O'Donohue J, Fullarton G, Imrie CW, Murray WR: Brush cytology in the assessment of pancreatico-biliary strictures: A review of 406 cases. J Clin Pathol 2001;54:449-455
39. Glasbrenner B, Ardan M, Boeck W, Preclik G, Moller P, Adler G: Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy 1999;31:712-717
40. Jailwala J, Fogel EL, Sherman S, Gottleib K, Flueckliger J, Bucksot LG, Lehman GA: Triple tissue sampling at ERCP in malignant biliary obstruction. Gastrointest Endosc 2000;51:383-390
41. Macken E, Drijkoningen M, Van Aken E, Van Steenbergen W: Brush cytology of ductal strictures during ERCP. Acta Gastroenterol Belg 2000;63:254-259
42. Fogel EL, deBellis M, McHenry L, Watkins JL, Chappo J, Cramer H, Schmidt S, Lazzell-Pannell L, Sherman S, Lehman GA: Effectiveness of a new long cytology brush in the evaluation of malignant biliary obstruction: A prospective study. Gastrointest Endosc 2006;63:71-77
43. Elek G, Gyokeres T, Schafer E, Burai M, Pinter F, Pap A: Early diagnosis of pancreatobiliary duct malignancies by brush cytology and biopsy. Pathol Oncol Res 2005;11:145-155
44. Ponsioen CY, Vrouenraets SME, van Milligen de Wit AWM, Sturm P, Tascilar M, Offerhaus GJ, Prins M, Huibregtse K, Tytgat GN: Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy 1999;31:305-309
45. Vandervoort J, Soetikno RM, Montes H, Lichtenstein DR, Van Dam J, Ruymann FW, Cibas ES, Carr-Locke DL: Accuracy and complication rate of brush cytology from bile duct versus pancreatic duct. Gastrointest Endosc 1999;49:322-327
46. Volmar KE, Vollmer RT, Routbort MJ, Creager AJ: Pancreatic and bile duct brushing cytology in 1000 cases: Review of findings and comparison of preparation methods. Cancer 2006 (e pub ahead of print)
47. Bardales RH, Stanley MW, Simpson DD, Baker SJ, Steele CT, Schaefer RF, Powers CN: Diagnostic value of brush cytology in the diagnosis of duodenal, biliary and ampullary neoplasms. Am J Clin Pathol 1998;109:540-548
48. Logrono R, Kurtycz DF, Molina CP, Trivedi VA, Wong JY, Block KP: Analysis of false-negative diagnoses on endoscopic brush cytology of biliary and pancreatic duct strictures: The experience at 2 university hospitals. Arch Pathol Lab Med 2000;124:387-389
49. Layfield LJ, Wax TD, Lee JG, Cotton PB: Accuracy and morphologic aspects of pancreatic and biliary duct brushings. Acta Cytol 1995;39:11-18
50. Evander A, Ihse I, Lunderquist A, Tylen U, Akerman M: Percutaneous cytodiagnosis of carcinoma of the pancreas and the bile duct. Ann Surg 1978;188:90-92
51. Harewood GC, Baron TH, Stadheim LM, Kipp BR, Sebo TJ, Salomao DR: Prospective, blinded assessment of factors influencing the accuracy of biliary cytology interpretation. Am J Gastroenterol 2004;99:1464-1469
52. Parasher VK, Huibregtse K: Endoscopic retrograde wire-guided cytology of malignant biliary strictures using a novel scraping brush. Gastrointest Endosc 1998;48:288-290
53. Logrono R, Wong JY: Reporting the presence of significant epithelial atypia in pancreaticobiliary brush cytology specimens lacking evidence of obvious carcinoma: Impact on performance measures. Acta Cytol 2004;48:613-621
54. Farrell RJ, Jain AK, Brandwein SL, Wang H, Chuttani R, Pleskow DK: The combination of stricture dilation, endoscopic needle aspiration, and biliary brushings significantly improves diagnostic yield from malignant bile duct strictures. Gastrointest Endosc 2001;54:587-594
55. Ornellas LC, Santos GD, Nakao FS, Ferrari AP: Comparison between endoscopic brush cytology performed before and after biliary stricture dilation for cancer detection. Arq Gastroenterol 2006;43:20-23
56. Kubota Y, Takaoka M, Tani K, Ogura M, Kin H, Fujimura K, Mizuno T, Inoue K: Endoscopic transpapillary biopsy for diagnosis of patients with pancreaticobiliary ductal strictures. Am J Gastroenterol 1993;88:1700-1704
57. McGuire DE, Venu RP, Brown RD, Etzkorn KP, Glaws WR, Abu-Hammour A: Brush cytology for pancreatic carcinoma: An analysis of factors influencing results. Gastrointest Endosc 1996;44:300-304
58. Elek G, Guori S, Toth B, Pap A: Histological evaluation of preoperative biopsies from ampulla Vateri. Pathol Oncol Res 2003;9:23-41
59. Pugliese V, Pujic N, Saccomanno S, Gatteschi B, Pera C, Aste H, Ferrera GB, Nicolo G: Pancreatic intraductal sampling during ERCP in patients with chronic pancreatitis and pancreatic cancer: Cytologic studies and k-ras-2 codon 12 molecular analysis in 47 cases. Gastrointest Endosc 2001;54:595-599
60. Renshaw AA, Madge R, Jiroutec M, Granter SR: Bile duct brushing cytology: Statistical analysis of proposed diagnostic criteria. Am J Clin Pathol 1998;110:635-640
61. Logrono R, Waxman I: Interactive role of the cytopathologist in EUS-guided fine needle aspiration: An efficient approach. Gastrointest Endosc 2001;54:485-590
62. Logrono R, Kurtycz DFI, Sproat IA, Shalkham JE, Stewart JA, Inhorn SL: Multidisciplinary approach to deep-seated lesions requiring radiologically- guided fine needle aspiration. Diagn Cytopathol 1998;18:338-342
63. Suen KC, Abdul-Karim FW, Kaminsky DB, Layfield LJ, Miller TR, Spires SE, Stanley DE: Guidelines of the Papanicolaou society of cytopathology for fine-needle aspiration procedure and reporting: The Papanicolaou Society of Cytopathology Task Force on Standards of Practice. Diagn Cytopathol 1997;17:239-247
64. Bardales RH, Stanley MW, Simpson DD, Baker SJ, Steele CT, Schaefer RF, Powers CN: Diagnostic value of brush cytology in the diagnosis of duodenal, biliary, and ampullary neoplasms. Am J Clin Pathol 1998;109:540-548
65. Leung CS, Brian C, Bell V: Comparison of Thin Prep and conventional preparations: Nongynecologic cytology evaluation. Diagn Cytopathol 1997;16:368-371
66. Michael CW, Hunter B: Interpretation of fine needle aspirates processed by the Thin Prep technique: Cytologic artifacts and diagnostic pitfalls. Diagn Cytopathol 2000;23:6-13
67. Siddiqui MT, Gokaslan ST, Saboorian MH, Ashfaq R: Split sample comparison of ThinPrep and conventional smears in endoscopic retrograde cholangiopancreatography-guided fine-needle aspirations. Diagn Cytopathol 2005;32:70-75
68. Wang HH, Sovie S, Trawinski G, Garcia LW, Abu-Jawdeh GM, Upton M, Wernecke S: Thin Prep processing of endoscopic brushing specimens. Am J Clin Pathol 1996;106:163-167
69. Khafaji BM, Afify AM: Salivary gland fine needle aspiration using the ThinPrep technique: Diagnostic accuracy, cytologic artifacts and pitfalls. Acta Cytol 2001;45:567-574
70. de Peralta-Venturina MN, Wong DK, Purslow MJ, Kini SR: Biliary tract cytology in specimens obtained by direct cholangiopancreatographic procedures: A study of 74 cases. Diagn Cytopathol 1996;14:334-348
71. Ylagan LR, Liu LH, Maluf HM: Endoscopic bile duct brushing of malignant pancreatic biliary strictures: Retrospective study with comparison of conventional smear and ThinPrep techniques. Diagn Cytopathol 2003;28:196-204
72. Centeno BA: Diagnostic cytology of the pancreas and biliary tract. In Surgical Pathology of the GI Tract, Biliary Tract and Pancreas. Edited by RD Odze, JR Goldblum, JM Crawford. Philadelphia, Saunders, 2004, pp 579-597
73. Cohen MB, Wittchow RJ, Johlin FC, Bottlers V, Raab SS: Brush cytology of the extrahepatic biliary tract: Comparison of cytologic features of adenocarcinoma and benign biliary strictures. Mod Pathol 1995;8:498-502
74. Vadmal MS, Byrne-Semmelmeier S, Smilari TF, Haidu SI: Biliary tract brush cytology. Acta Cytol 2000;44:533-538
75. Nakajima T, Tajima Y, Sugano I, Nagao K, Sakuma A, Koyama Y, Kondo Y: Multivariate statistical analysis of bile cytology. Acta Cytol 1994;38:51-55
76. Thabet RJ, Farlane EWE: Cytologic field pattern and nuclear morphology in the diagnosis of colon pathology. Acta Cytol 1962;6:325-331
77. Yamada T, Murohisa B, Muto Y, Okamoto K, Doi K, Tsuchiya R: Cytologic detection of small pancreaticoduodenal and biliary cancers in the early developmental stages. Acta Cytol 1984;28:435-442
78. Ryan ME: Cytologic brushings of ductal lesions during ERCP. Gastrointest Endosc 1991;37:139-142
79. Okonkwo AM, De Frias DV, Gunn R, Diaz L, Schindler S, Lal A: Reclassification of "atypical" diagnoses in endoscopic retrograde cholangiopancreatography-guided biliary brushings. Acta Cytol 2003;47:435-442
80. Hruban RH, van Mansfield ADM, Offerhaus GJA, van Weering DH, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL: K-Ras oncogene activation in adenocarcinoma of the human pancreas: A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993;143:545-554
81. Sohn TA, Yeo CJ: The molecular genetics of pancreatic ductal carcinoma: A review. Surg Oncol 2000;9:95-101
82. Lebe B, Sagol O, Ulukus C, Coker A, Karademir S, Astarcioglu H, Kuperlioglu A: The importance of cyclin D1 and Ki67 expression on the biological behavior of pancreatic adenocarcinomas. Pathol Res Pract 2004;200:389-396
83. Dong M, Ma G, Tu W, Guo KJ, Tian YL, Dong YT: Clinicopathological significance of p53 and mdm2 protein expression in human pancreatic cancer. World J Gastroenterol 2005;11:2162-2165
84. Itoi T, Takei K, Sofuni A, Itokawa F, Tsuchiya T, Kurihara T, Nakamura K, Moriyasu F, Tsuchida A, Kasuya K: Immunohistochemical analysis of p53 and MIB-1 in tissue specimens obtained from endoscopic ultrasonography-guided fine needle aspiration biopsy for the diagnosis of solid pancreatic masses. Oncol Rep 2005;13:229-234
85. Al-Aynati MM, Radulovich N, Ho J, Tsao MS: Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis. Clin Cancer Res 2004;10:6598-6605
86. Wilentz RE, Su GH, Dai JL, Sparks AB, Sohn TA, Yeo CJ, Kern SE, Hruban RH: Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: A new marker of DPC4 inactivation. Am J Pathol 2000;156:37-43
87. Tascilar M, Offerhaus GJ, Altink R, Argani P, Sohn TA, Yeo CJ, Cameron JL, Goggins M, Hruban RH, Wilentz RE: Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct. Am J Clin Pathol 2001;116:831-837
88. Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, Moskaluk CA, Hahn SA, Schwarte-Waldhoff I, Schmiegel W, Baylin SB, Kern SE, Herman JG: Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 1997;57:3126-3130
89. Luttges J, Feyerabend B, Buchelt T, Pacena M, Kloppel G: The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 2002;26:466-471
90. Taniai M, Higuchi H, Burgart LJ, Gores GJ: p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma. Gastroenterology 2002;123:1090-1098
91. Ahrendt SA, Rashid A, Chow JT, Eisenberger CF, Pitt HA, Sidransky D: p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer. J Hepatobiliary Pancreat Surg 2000;7:426-431
92. Levi S, Urbano-Ispizua, Gill R, Eisenberger CF, Pitt HA, Sidransky D: Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991;51:3497-3502
93. Niiyama H, Mizumoto K, Kusumoto M, Ogawa T, Suehara N, Shimura H, Tanaka M: Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms. Cancer 1999;85:2138-2143
94. Almoguera C, Shibata D, Forrester K, Arnheim N, Perucho M: Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988;53:549-554
95. Caldas C, Kern SE: K-ras mutations and pancreatic adenocarcinoma. Int J Pancreatol 1995;18:1-6
96. Van Laethem JL, Vertongen P, Deviere J, Van Rampelbergh J, Rickaert F, Cremer M, Robberecht P: Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours. Gut 1995;36:781-787
97. Sturm P, Hruban RH, Ramsoekh TB, Noorduyn LA, Tytgat GN, Gouma DJ, Offerhaus GJ: The potential diagnostic use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region. J Pathol 1998;186:247-253
98. van Heek NT, Clayton SJ, Sturm PD, Walker J, Gouma DJ, Noorduyn LA, Offerhaus GJ, Fox JC: Comparison of the novel quantitative ARMS assay and an enriched PCR-ASO assay for K-ras mutations with conventional cytology on endobiliary brush cytology from 312 consecutive extrahepatic biliary stenoses. J Clin Pathol 2005;58:1315-1320
99. Ishimaru S, Itoh M, Hanada K, Tsuchida A, Iwao T, Kajiyama G: Immunocytochemical detection of p53 protein from pancreatic duct brushings in patients with pancreatic carcinoma. Cancer 1996;77:2233-2239
100. Iwao T, Tsuchida A, Hanada K, Eguchi N, Kajiyama G, Shimamoto F: Imunohistochemical detection of p53 protein as an adjunct in cytologic diagnosis from pancreatic duct brushings in mucin-producing tumors of the pancreas. Cancer 1997;81:163-171
101. Stewart CJR, Burke GM: Value of p53 immunostaining in pancreaticobiliary brush cytology specimens. Diagn Cytopathol 2000;23:308-313
102. Krishnamurthy S, Katz RL, Shumate A, Strohlein K, Khanna A, Tucker SL: DNA image analysis combined with routine cytology improves diagnostic sensitivity of common bile duct brushing. Cancer 2001;93:229-235
103. Yeaton P, Kiss R, Deviere J, Salmon I, Bourgeois N, Pasteels JL, Cremer M: Use of cell image analysis in the detection of cancer from specimens obtained during endoscopic retrograde cholangiopancreatography. Am J Clin Pathol 1993;100:497-501
104. Ryan ME, Baldauf MC: Comparison of flow cytometry for DNA content and brush cytology for detection of malignancy in pancreaticobiliary strictures. Gastrointest Endosc 1994;40:133-139
105. Osterheld MC, Andrejevic Blant S, Caron L, Braunsweig R, Dorta G, Bouzourene H, Mihaescu A: Digital image DNA cytometry: A useful tool for the evaluation of malignancy in biliary strictures. Cell Oncol 2005;27:255-260
106. Bergquist A, Lindberg B, Castro J, Tribukait B: Methodologic aspects of evaluating brush samples from biliary strictures by cytology and DNA flow cytometry. Acta Cytol 2004;48:341-347
107. Khalid A, Pal R, Sasatomi E, Swalsky P, Slivka A, Whitcomb D, Finkelstein S: Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples. Gut 2004;53:1860-1865
108. Kipp BR, Stadheim LM, Halling SA, Pochron NL, Harmsen S, Nagorney DM, Sebo TJ, Therneau TM, Gores GJ, de Groen PC, Baron TH, Levy MJ, Halling KC, Roberts LR: A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol 2004;99:1675-1681
109. Mahlamaki EH, Barlund M, Tanner M, Gorunova L, Hoglund M, Karhu R, Kallioniemi A: Frequent amplification of 8q24 , 11q , 17q , and 20-q specific genes in pancreatic cancer. Genes Chromosomes Cancer 2002;35:353-358
110. Schleger C, Arens N, Zentgraf H, Bleyl U, Verbeke C: Identification of frequent chromosomal aberrations in ductal adenocarcinoma of the pancreas by comparative genomic hybridization (CGH). J Pathol 2000;191:27-32
111. Skacel M, Fahmy M, Brainard JA, Pettay JD, Biscotti CV, Liou LS, Procop GW, Jones JS, Ulchaker J, Zippe CD, Tubbs RR: Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol 2003;169:2101-2105
112. Veeramachaneni R, Nordberg ML, Shi R, Herrera GA, Turbat-Herrera EA: Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma. Diagn Cytopathol 2003;28:301-307
113. Swierczynski SL, Maitra A, Abraham SC, Iacobuzio-Donahue CA, Ashfaq R, Cameron JL, Schulick RD, Yeo CJ, Rahman A, Hinkle DA, Hruban RH, Argani P: Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. Hum Pathol 2004;35:357-366
114. Hansel DE, Rahman A, Hidalgo M, Thuluvath PJ, Lillemoe KD, Shulick R, Ku JL, Park JG, Miyazaki K, Ashfaq R, Wistuba II, Varma R, Hawthorne L, Geradts J, Argani P, Maitra A: Identification of novel targets of biliary tract cancers using global gene expression technology. Am J Pathol 2003;163:217-229
115. Argani F, Rosty C, Reiter RE, Wilentz RE, Murugesan SR, Leach SD, Ryu B, Skinner HG, Goggins M, Jaffee EM, Yeo CJ, Cameron JL, Kern SE, Hruban RH: Discovery of new markers through serial analysis of gene expression (SAGE): Prostate stem cell antigen (PSCA) is overexpressed in pancreatic adenocarcinoma. Cancer Res 2001;61:4320-4324
116. Argani P, Iacobuzio-Donahue CA, Ryu B, Rosty C, Goggins M, Wilentz RE, Murugesan SR, Leach SD, Jaffee E, Yeo CJ, Kern SE, Hruban RH: Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: Identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res 2001;7:3862-3868
117. Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL, van Heek T, Ashfaq R, Meyer R, Walter K, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M, Hruban RH: Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol 2002;160:1239-1249
118. Hustinx SR, Cao D, Maitra A, Sato N, Martin ST, Sudhir D, Iacobuzio-Donahue CA, Cameron JL, Yeo CJ, Kern SE, Goggins M, Mollenhauer J, Pandey A, Hruban RH: Differentiating expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression. Cancer Biol Ther 2004;3:1254-1261
119. Watanabe H, Okada G, Ohtsubo K, Yamaguchi Y, Mouri H, Motoo Y, Wakabayashi T, Sawabu N: Expression of mesothelin mRNA in pure pancreatic juice form patient with pancreatic carcinoma, intraductal papillary mucinous neoplasm of the pancreas and chronic pancreatitis. Pancreas 2005;30:349-354